LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
SK-BR-3 Radicicol
3.33
uM
LJP6
 0.3787 0.0195 -0.0342 0.0588
SK-BR-3 Seliciclib
3.33
uM
LJP5
 0.8013 0.0249 0.6735 0.0248
SK-BR-3 Ruxolitinib
3.33
uM
LJP5
 0.9920 0.0309 0.9858 0.0507
SK-BR-3 XL147
3.33
uM
LJP5
 1.1328 0.0271 1.2180 0.0407
SK-BR-3 Saracatinib
3.33
uM
LJP6
 0.8335 0.0116 0.7206 0.0333
SK-BR-3 Selumetinib
3.33
uM
LJP6
 0.9974 0.0194 0.9919 0.0320
SK-BR-3 Sirolimus
3.33
uM
LJP6
 0.6005 0.0125 0.3351 0.0354
SK-BR-3 Sorafenib
3.33
uM
LJP6
 1.0023 0.0268 1.0036 0.0445
SK-BR-3 SU11274
3.33
uM
LJP5
 0.9653 0.0228 0.9467 0.0350
SK-BR-3 Fedratinib
3.33
uM
LJP5
 0.6892 0.0457 0.4874 0.0663
SK-BR-3 TGX221
3.33
uM
LJP5
 0.9943 0.0040 0.9907 0.0067
SK-BR-3 Torin1
3.33
uM
LJP6
 0.3161 0.0114 -0.1422 0.0861
SK-BR-3 Torin2
3.33
uM
LJP5
 0.2874 0.0179 -0.1852 0.0510
SK-BR-3 Tozasertib
3.33
uM
LJP5
 0.3473 0.0046 -0.0871 0.0571
SK-BR-3 Trametinib
3.33
uM
LJP5
 0.7726 0.0304 0.6178 0.0621
SK-BR-3 TWS119
3.33
uM
LJP5
 0.6867 0.0160 0.4756 0.0512
SK-BR-3 Vemurafenib
3.33
uM
LJP5
 0.9800 0.0318 0.9728 0.0500
SK-BR-3 Withaferin A
3.33
uM
LJP5
 0.2570 0.0344 -0.2325 0.0364
SK-BR-3 Withaferin A
3.33
uM
LJP6
 0.2372 0.0079 -0.2704 0.0661
SK-BR-3 WYE-125132
3.33
uM
LJP6
 0.3670 0.0104 -0.0566 0.0764
SK-BR-3 WZ3105
3.33
uM
LJP5
 0.2608 0.0307 -0.2318 0.0887
SK-BR-3 XMD11-50
3.33
uM
LJP6
 0.5927 0.0332 0.3147 0.0933
SK-BR-3 Y39983
3.33
uM
LJP6
 0.6960 0.0453 0.4863 0.0967
SK-BR-3 YM 201636
3.33
uM
LJP5
 0.8619 0.0199 0.7720 0.0294
SK-BR-3 ZSTK474
3.33
uM
LJP6
 0.3849 0.0104 -0.0266 0.0744